TIP_link_300x300.jpg
$32.4 Bn Cell Therapy Instruments Market to Exhibit CAGR of 13.2% by 2027, Deep Dive Analysis of Key Players and Growth Opportunities
November 15, 2022 08:17 ET | The Insight Partners
New York, Nov. 15, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "Cell Therapy Instrument Market Size, Share, Growth, Trends and Forecast to 2027 – COVID-19 Impact and...
researchdrivelogo.jpg
Global Carrier Screening Market Anticipated to Garner a Revenue of $7,157.60 Million and Grow at a CAGR of 16.20% during the Analysis Period from 2021 to 2028 | Exclusively Available [165-Pages] by Research Dive
March 15, 2022 09:03 ET | Research Dive
New York, USA, March 15, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global carrier screening market is expected to generate a revenue of $7,157.60 million and...
AMR Logo.png
Gene Therapy Market to Reach $6.21 Billion by 2026: Allied Market Research
August 05, 2020 10:24 ET | Allied Market Research
Portland, OR, Aug. 05, 2020 (GLOBE NEWSWIRE) -- According to the report, the global Gene Therapy Market was pegged at $393.35 million in 2018, and is projected to reach $6.21 billion by 2026,...
energias.jpg
Global Genetic Testing Market to Witness a CAGR of 12.2% during 2018-2024
October 08, 2018 05:26 ET | Energias Market Research
NEW YORK, Oct. 08, 2018 (GLOBE NEWSWIRE) -- The global genetic testing market is expected to grow significantly from USD 8,531.4 million in 2017 to USD 19,112.4 million in 2024, at a CAGR of 12.2%...
Metabolon's Platform
Metabolon's Platform for Clinical Triaging of Inborn Errors of Metabolism Verified by Baylor College of Medicine
October 22, 2014 11:46 ET | Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C. and HOUSTON, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that its Global Metabolomic-Assisted Pathway Screen (MAPS)...